:max_bytes(150000):strip_icc()/GettyImages-22542924961-4b359dd70fa04a2c9aaa74e697b0dda3.jpg "Why Berkshire Hathaway Stock Could Outperform as Geopolitical Tensions Rise")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-22542924961-4b359dd70fa04a2c9aaa74e697b0dda3.jpg)
Key Takeaways
- UBS analysts said they expect Berkshire Hathaway’s stock to outperform the broader market amid heightened volatility.
- A preference for less-risky plays could benefit Berkshire Hathaway, which “is generally considered very defensive,” according to UBS.
Berkshire Hathaway could be set for outperformance as geopolitical tensions rise, according to one Wall Street firm.
Analysts at UBS, in a note to clients, said they “anticipate BRK’s shares will outperform the broader market given the elevated geopolitical tensions”.
Shares of the conglomerate (BRK.A, BRK.B) rose slightly Tuesday while the major indexes lost ground. Worries about developments in Iran after the U.S. and Israel launched a joint attack over the weekend have rattled markets to start to the week, driving investors into stocks seen as defensive plays.
Why This Is Significant
When geopolitical conflicts drive heightened volatility, investors tend to seek refuge in traditional safe haven and defensive assets. Those impulses could benefit Berkshire Hathaway.
“Historically, BRK shares have outperformed during periods of market volatility benefiting from their diversified earnings streams, liquidity position, and largely US focused businesses,” UBS wrote.
The firm added that Berkshire’s annual letter over the weekend reiterated core principles and values supporting those expectations, though sentiment around the stock has taken a hit after a disappointing fourth-quarter report.
Berkshire’s financial results released over the weekend revealed a nearly 30% year-over-year drop in operating earnings during Warren Buffett’s final quarter as CEO, as the company took write-downs of its stakes in Kraft Heinz (KHC) and Occidental Petroleum (OXY).
Investors sent the conglomerate’s class B shares down 5% Monday following the release, dragging them into negative territory for the year.
UBS lowered its 12-month price target for the shares to $578 from $587. That would still suggest 20% upside from their closing level on Tuesday.
